U.S. markets close in 58 minutes

Surmodics, Inc. (SRDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
59.26+0.53 (+0.89%)
As of 2:56PM EDT. Market open.

Surmodics, Inc.

9924 West 74th Street
Eden Prairie, MN 55344
United States
952 500 7000
http://www.surmodics.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees370

Key Executives

NameTitlePayExercisedYear Born
Mr. Gary R. MaharajCEO, Pres & Director1.13MN/A1963
Mr. Timothy J. ArensSr. VP of Fin. & Information Technology and CFO509.4k152.32k1967
Ms. Teryl L. W. SidesSr. VP of Product Devel. & Chief Marketing Officer538.71kN/A1969
Mr. Joseph J. StichSr. VP & GM of HR - In Vitro Diagnostics508.75k282.38k1965
Mr. John D. MandersCorp. Controller & Principal Accounting OfficerN/AN/A1981
Mr. Gordon S. WeberSr. VP of Legal, Gen. Counsel & Sec.N/AN/A1963
Mr. Charles W. OlsonSr. VP of Commercial & Bus. Devel. - Medical DevicesN/AN/A1964
Mr. Gregg S. SuttonVP of R&D - Medical DevicesN/AN/A1960
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The Vitro Diagnostics segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Corporate Governance

Surmodics, Inc.’s ISS Governance QualityScore as of April 1, 2021 is 4. The pillar scores are Audit: 9; Board: 2; Shareholder Rights: 5; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.